Shaping the Investment and Policy Pathway for a Next-Generation Tuberculosis Vaccine
Supporting Global Vaccine Policy Through the WHO’s Strategic Advisory Group of Experts
Building Country Capacity for Oral Cholera Vaccine Campaign Implementation
Measuring COVID-19 Vaccine Effectiveness in the Eastern Mediterranean Region
Advancing Global Vaccine Market Transparency through the WHO Market Information for Access to Vaccines Initiative
Building a Global Evidence Platform for Country Vaccine Decision-Making
Securing Gavi Support for Vaccine Introductions and Campaigns
Improving COVID-19 Vaccine Introduction Through Post-Introduction Evaluations
Defining the Conditions for an Effective Vaccine Development Ecosystem
Designing the Market Shaping Roadmap for Novel Tuberculosis Vaccines
Shaping the European Immunization Agenda 2030 and Its Operational Framework
Prioritising Research to End Cholera
Supporting Global COVID-19 Vaccine Rollout Through COVAX Country Readiness and Delivery
Preparing Health Systems for Group B Streptococcal Maternal Vaccination
Assessing WHO’s Role in Supporting COVID-19 Sero-Epidemiologic Research
Reviewing Enteric Fever Surveillance Pilots in Ghana
Charting the Commercial Pathway for a Leishmaniasis Vaccine
Assessing Regional COVID-19 Vaccine Manufacturing Capacity in Asia
Designing Gavi’s Market Shaping Strategy for the 6.0 Strategic Period
Building the Business Case for Eliminating Onchocerciasis and Lymphatic Filariasis
Shaping the Measles and Rubella Global Strategic Framework 2021–2030
Aligning Research Investments with Lassa Fever Vaccine Policy Needs
Monitoring Progress Under the European Immunization Agenda 2030
Defining Subnational Use and Demand for Measles-Rubella Vaccine Patches
Identifying Enablers of Accelerated COVID-19 Vaccine Development and Approval
Establishing the Full Value Assessment for Measles-Rubella Microarray Patches
Evaluating Vaccine Manufacturing Self-Sufficiency in Central and South America
Designing a Policy Framework for Emerging Tuberculosis Vaccines
Defining a Prioritised Research Agenda to Support Country Implementation of Measles-Rubella Microarray Patches
Operationalising Equity in Immunisation Programmes
Enhancing Vaccine Procurement Practices in South-Eastern Europe
Establishing a National Programme Performance Monitoring Framework in Myanmar
Preparing Countries for Pandemic Influenza Vaccine Deployment
Analysing the Impact of Electronic Immunisation Registries and Logistics Systems
Measuring Progress Under the Global Vaccine Action Plan
Strengthening the Effectiveness of WHO’s Strategic Advisory Group of Experts
Assessing Market Viability for Typhoid Conjugate Vaccine Microarray Patches
Defining Market Potential for Measles Combination Vaccine Patches
Modelling Global Demand and Financial Sustainability for a Group B Streptococcal Vaccine
Accelerating Regional Control of Japanese Encephalitis
Optimising Maternal Immunisation Delivery and Antenatal Care Systems
Reinforcing Enteric Fever Surveillance in India
Identifying Gaps in Maternal Immunisation Acceptability and Access
Reviewing the UN Supply Chain Response to the COVID-19 Pandemic
Securing Access to Meningitis Vaccines
Articulating the Full Value of Improved Seasonal Influenza Vaccines
Identifying Barriers to Access and Affordability for Human Papillomavirus Vaccines
Reforming the Mandate and Governance of the Immunisation Practices Advisory Committee
Delivering a Comprehensive Multi-Year Immunisation Plan for Lao PDR
Setting the Strategic Direction for Health Worker Learning and Performance
Measuring the Impact of the Childhood Pneumonia Programme in India
Reviewing the European Vaccine Action Plan 2015–2020
Examining the Integration of Supplementary and Routine Immunisation in Nepal
Structuring a Sustainable Financing Framework for Neglected Tropical Diseases
Expanding Clinical Trial Manufacturing Capacity for Influenza Vaccines
Improving Vaccine Access in European Middle-Income Countries
Advancing the Policy Pathway for an Invasive Non-Typhoidal Salmonella Vaccine
Sustaining Innovation in Heat-Stable Vaccines and Controlled Temperature Chain
Developing the Measles and Rubella Elimination Strategy for the European Region
Reviewing the Regional Strategic Plan for Immunisation in Africa
Evaluating Influenza Vaccine Introduction in Middle-Income Countries
Strengthening Oral Cholera Vaccine Delivery through Lessons from Haiti